List of substances prohibited for circulation in the Russian Federation. Narcotic psychotropic drugs and substances: a complete list. List of psychotropic and narcotic drugs and substances

LIST OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES SUBJECT TO CONTROLIN RUSSIAN FEDERATION

(according to the government decree of June 30, 1998 N 681, as amended, coming into force on 01/01/2013)

The circulation of these substances in Russia is prohibited under threat of punishment.

list of drugs,

psychotropic substances, circulation of which

in the Russian Federation is prohibited in accordance

with the legislation of the Russian Federation and international

treaties of the Russian Federation (list I)

(As amended by Decree of the Government of the Russian Federation dated November 23, 2012 N 1215)

Narcotics

N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

N-(adamantan-1-yl)-1-pentyl-1H-indole-3-carboxamide and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

3-Adamantoylindole [(Adamantan-1-yl)(1H-indol-3-yl)methanone] and its derivatives, with the exception of derivatives included as independent items in the list

Allylprodine

Alfameprodine

Alfamethadol

Alpha-methylfentanyl

Alpha-methylthiofentanyl

Alphaprodin

Alphaacetylmethadol

2-Amino-1-benzodifuran-4-ylethane and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

2-Aminoindan and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

AMT (alpha-methyltryptamine) and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of May 18, 2012 N 491)

anileridin

Acetyl-alphamethylfentanyl

Acetyldihydrocodeine

Acetylated opium

Acetylcodeine

Acetylmethadol

Acetylfentanyl (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

7-Acetoxymitragynine (introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

Acetorphin

bdb

Bezitramid

Benzetidine

benzylmorphine

3-Benzoylindole [(1H-indol-3-yl)phenylmethanone] and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

Beta-hydroxy-3-methylfentanyl

Beta-hydroxyfentanyl

Betameprodine

Betamethadol

Betaprodin

Betacetylmethadol

Brolamphetamine (DOB, d, L-4-bromo-2,5-dimethoxy-alpha-methyl-phenethylamine)

3-Butanoyl-1-methylindole and its derivatives, with the exception of derivatives included as independent items in the list

3-Butanoyl-1-methylindole and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of February 22, 2012 N 144)

(1-Butyl-1H-indol-3-yl) (naphthalen-1-yl) methanone (-073) and its derivatives, except for derivatives included as independent items in the list

hydrocodone

4-Hydroxytryptamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

5-Hydroxy-N-methyltryptamine and its derivatives, with the exception of derivatives included as independent entries in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

N-hydroxy-MDA

7-Hydroxymitragynine

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

Hydroxypethidine

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol (CP 47.497) and its derivatives, with the exception of derivatives included as independent entries in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methylheptan-2-yl)phenol (CP 47,497)-C6) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyldecan-2-yl)phenol (CP 47,497)-C9) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol (CP 47,497)-C8) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

Hydromorphinol

6-deoxycodeine

The position is excluded. - Decree of the Government of the Russian Federation of March 11, 2011 N 158

Desomorphine

Dihydromorphine

Dimenoxadol

N-dimethylamphetamine

Dimethocaine [(3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate]

(introduced by Decree of the Government of the Russian Federation of February 22, 2012 N 144)

2,5-Dimethoxyphenethylamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

Dimepheptanol

Dimethylthiambutene

(6aR, 10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7, 10, 10a-tetrahydrobenzo[c]chromen-1-ol (HU- 210) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

2C-T-7 (2,5-dimethoxy-4-N-propylthiopheneethylamine)

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Dioxafetyl butyrate

Dipipanon

Diphenoxin

Diethylthiambutene

DMA (d,L-2,5-dimethoxy-alpha-methyl-phenyl-ethylamine)

DMHP (dimethylheptylpyran)

DMT (dimethyltryptamine) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

DOC (d, L-2,5-dimethoxy-4-chloro-amphetamine)

DOET (d, L-2,5-dimethoxy-4-ethyl-amphetamine)

Drotebanol

DET (N,N-diethyltryptamine)

Ketobemidone

Clonitazen

Kodoxim

The position is excluded. - Decree of the Government of the Russian Federation of November 27, 2010 N 934

Homemade preparations from ephedrine (pseudoephedrine) or from preparations containing ephedrine (pseudoephedrine)

The position is excluded. - Decree of the Government of the Russian Federation of 03.03.2012 N 169

Handicraft preparations from phenylpropanolamine or from preparations containing phenylpropanolamine (introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Levomethorphan

Levomoramid

Levorphanol (lemoran)

Levofenacylmorphan

Position retired as of January 1, 2013. - Decree of the Government of the Russian Federation of 01.10.2012 N 1003

The position is excluded. - Decree of the Government of the Russian Federation of November 27, 2010 N 934

MBDB

MDA (tenamphetamine)

MDMA (d, L-3,4-methylenedioxy-N-alpha-dimethyl-phenyl-ethylamine)

3-Monoacetylmorphine

6-Monoacetylmorphine

Mescaline

Methadone (phenadone, dolophine)

(As amended by Decree of the Government of the Russian Federation of 30.06.2010 N 486)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Methadone intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane)

Metazocin

methamphetamine (pervitin)

(As amended by Decree of the Government of the Russian Federation of 30.06.2010 N 486)

Methyldesorphin

Methyldihydromorphine

Methylenedioxypyrovalerone (introduced by Decree of the Government of the Russian Federation of February 25, 2011 N 112)

6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one

(introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

Methylone (3,4-methylenedioxy-N-methylcathinone)

2-Methyl-1-pentyl-1H-indol-3-yl-(1-naphthyl)methane (JWH-196) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

2-Methyl-1-pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane (JWH-194) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

2-Methyl-1-pentyl-1H-indol-3-yl-(4-methoxy-1-naphthyl)methane (JWH-197) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (JWH-007) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(4-Methylnaphthalene-1-yl)(2-methyl-1-pentyl-1H-indo-3-yl)methanone (JWH-149) and its derivatives, with the exception of derivatives included as independent entries in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(2-Methyl-1-pentyl-1H-indol-3-yl) (4-methoxynaphthalen-1-yl) methanone (JWH-098) and its derivatives, except for derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

3-methylthiofentanyl

3-methylfentanyl

N-methylephedron and its derivatives, with the exception of derivatives included as independent items in the list

Methoxetamine and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

N--2,2,3,3-tetramethylcyclopropane-1-carboxamide (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

Mephedrone (4-methylmethcathinone)

(Introduced by Decree of the Government of the Russian Federation of July 29, 2010 N 578)

Mitragynine (9-methoxy-corynantheidine) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

The milky juice of various poppy species that are not sleeping pills (Papaver somniferum L) but contain poppy alkaloids included in the lists of narcotic drugs and psychotropic substances

MMDA (2-methoxy-alpha-4-methyl 4,5-(methylenedioxy)-phenethylamine)

Moramide, intermediate (2-methyl-3-morpholine-1, 1-diphenyl-propane-carboxylic acid)

Morferidine

Morphine methyl bromide

Morphine-N-oxide

JWH-195) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(4-Methylnaphthalene-1-yl)(1--1H-indol-3-yl)methane (JWH-192) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(4-Methoxy-1-naphthyl)(1--1H-indol-3-yl)methane (JWH-199) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(1--1H-indol-3-yl)(naphthalen-1-yl)methanone (JWH-200) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(4-Methylnaphthalen-1-yl)(1--1H-indol-3-yl)methanone (JWH-193) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(4-Methoxy-1-naphthyl)(1--1H-indol-3-yl)methanone (JWH-198) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

MPPP (MPPP (1-methyl-4-phenyl-4-piperidinol propionate (ether))

(As amended by Decree of the Government of the Russian Federation of 30.06.2010 N 486)

(E)-1-pentane (JWH-176) and its derivatives, with the exception of derivatives included as independent entries in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(Naphthalen-1-yl)(1H-pyrrol-3-yl) methanone and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

(Naphthalen-1-yl) (4-pentyloxynaphthalen-1-yl) methanone and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of May 18, 2012 N 491)

3-Naphthoylindole [(1H-indol-3-yl)(naphthalene-1-yl)methanone] and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

nicodicodin

Nicocodin

nicomorphine

Noracimetadol

Norcodeine

Norlevorphanol

Normethadone

Normorphine

Norpipanon

Oxymorphone

- coagulated poppy juice (Papaver somniferum L)

(as amended by Decree of the Government of the Russian Federation of November 27, 2010 N 934)

The position is excluded. - Decree of the Government of the Russian Federation of November 27, 2010 N 934

oripavin

Para-fluorofentanyl (para-fluorofentanyl)

parahexyl

(4-Methylnaphthalene-1-yl)(1-pentyl-1H-indol-3-yl)methanone (JWH-122) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(4-Methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (JWH-081) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

(Naphthalen-1-yl) (1-pentyl-1H-indol-3-yl) methanone (JWH-018) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

1-Pentyl-1H-indol-3-yl-(1-naphthyl)methane (JWH-175) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

1-Pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane (JWH-184) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

1-Pentyl-1H-indol-3-yl-(4-methoxy-1-naphthyl)methane (JWH-185) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

PEPAP (L-phenethyl-4-phenyl-4-piperidinol acetate (ether))

Pethidine Intermediate A (4-cyano-1-methyl-4-phenylpiperidine)

Pethidine Intermediate B (4-phenylpiperidine-4-carboxylic acid ethyl ester)

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Pethidine, Intermediate C (1-methyl-4-phenylpiperidine-4-carboxylic acid)

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Piminodin

(Piperidin-2-yl)diphenylmethane and its derivatives, with the exception of derivatives included as independent entries in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

(Pyrrolidin-2-yl)diphenylmethane and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

The position is excluded. - Decree of the Government of the Russian Federation of November 27, 2010 N 934

PMA (4-methoxy-alpha-methylphenyl-ethylamine)

Proheptazin

The position is excluded. - Decree of the Government of the Russian Federation of 08.07.2006 N 421

The position is excluded. - Decree of the Government of the Russian Federation of 08.07.2006 N 421

psilocybin

psilocin

Racemethorphan

Racemoramide

Racemorphan

Rolicyclidine

Salvinorin A

(introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186)

2С-В (4-bromo-2,5-dimethoxyphenethylamine)

STP (HOUSE)

The position is excluded. - Decree of the Government of the Russian Federation of November 27, 2010 N 934

Tebacon (Acetyldihydrocodeinone)

(As amended by Decree of the Government of the Russian Federation of 30.06.2010 N 486)

Tenocyclidine (TCP)

(As amended by Decree of the Government of the Russian Federation of 30.06.2010 N 486)

(all isomers)

2-thiophen-2-ylethylamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

Thiofentanil

TMA (d,L-3,4,5-trimethoxy-alpha-methylphenyl-amine)

TFMPP (1-(3-trifluoromethylphenyl)piperazine)

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Fenadoxone

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Phenazocin

Fenampromide

1-Phenylpiperazine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

1-Phenylcyclohexylamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

Phenylacetylindole and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation of 07.07.2011 N 540)

phencyclidine

Phenomorphan

Phenoperidine

Fenfluramine

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Folcodin

Furetidine

Chlorphenylpiperazine

(introduced by Decree of the Government of the Russian Federation of June 30, 2010 N 486)

The position is excluded. - Decree of the Government of the Russian Federation of November 27, 2010 N 934

Ecgonine, its esters and derivatives, which can be converted to ecgonine and cocaine

Poppy straw extract (poppy straw concentrate)

N-ETHYL-MDA (d, L-N-ethyl-alpha-methyl-3,4-(methylenedioxy) - phenethylamyl)

Ethylmethylthiambutene

1-Ethyl-1-pentyl-3-(1-naphthoyl)indole (JWH-116) and its derivatives, with the exception of derivatives included as independent items in the list

(Introduced by Decree of the Government of the Russian Federation of December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

Ethycyclidine

Ethoxeridine

Etonitazen

Etryptamine

Ephedron (methcathinone) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

Psychotropic substances

Amphetamine and its derivatives, with the exception of derivatives included as independent entries in the list

(as amended by Decrees of the Government of the Russian Federation of 30.06.2010 N 486, of 07.07.2011 N 540)

Cathin (d-norpseudoephedrine)

Cathinone (L-alpha-aminopropiophenone) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

The position is excluded. - Decree of the Government of the Russian Federation of 08.07.2006 N 421

Mecloqualone

Methaqualone

4-methylaminorex

Methylphenidate (Ritalin)

Fenetylline

(introduced by Decree of the Government of the Russian Federation of June 30, 2010 N 486)

1-Phenyl-2-propanone (introduced by Decree of the Government of the Russian Federation of April 21, 2010 N 255)

Isomers, including stereoisomers (unless expressly excluded), of the narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such isomers, including stereoisomers, is possible within the framework of this chemical designation

(as amended by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Esters of complex and simple narcotic drugs and psychotropic substances listed in this list

All mixtures containing narcotic drugs and psychotropic substances of this list, regardless of their quantity

List of drugs

and psychotropic substances, circulation of which

which control measures are established in accordance with

with the legislation of the Russian Federation

and international treaties of the Russian

Federations (list II)

Narcotics

p-Aminopropiophenone (PAPP) and its optical isomers (cyanide antidote)

Alfentanil

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

BZP (N-benzylpiperazine) and its derivatives, with the exception of derivatives included as independent entries in the list

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421, as amended by Decree of the Government of the Russian Federation of 06.10.2011 N 822)

Buprenorphine

Hydromorphone

(introduced by Decree of the Government of the Russian Federation of March 11, 2011 N 158)

Glutethimide (Noxiron)

Dextromoramide

Dextropropoxyphene (ibuproxiron, proxivon, spasmoproxyvon)

Dihydrocodeine

Dihydroetorphine

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

diphenoxylate

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Codeine N-oxide

4-MTA (alpha-methyl-4-methylthiophenetylamine)

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Morphylong

Oxycodone (tecodin)

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Pentazocine

Properidine

Propiram

Prosidol

Pyritramide (dipidolor)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Remifentanil

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Sombrevin

Sufentanil

Alnagon tablets (codeine phosphate 20 mg, caffeine 80 mg, phenobarbital 20 mg, acetylsalicylic acid 20 mg)

Tablets (codeine camphosulfonate 0.025 g, potassium sulfagviacol 0.100 g, grindelia thick extract 0.017 g)

Codeine tablets 0.03 g + paracetamol 0.500 g

Codeine phosphate tablets 0.015 g + sugar 0.25 g

Codeine tablets 0.01 g, 0.015 g + sugar 0.25 g

Codeine tablets 0.015 g + sodium bicarbonate 0.25 g

Tablets "Codterpin" (codeine 0.015 g + sodium bicarbonate 0.25 g + terpinhydrate 0.25 g)

Cough tablets. Ingredients: thermopsis herbs in powder - 0.01 g (0.02 g), codeine - 0.02 g (0.01 g), sodium bicarbonate - 0.2 g, licorice root in powder - 0.2 g

Trimeperidine (promedol)

Fentanyl

ethylmorphine

The position is excluded. - Decree of the Government of the Russian Federation of 08.07.2006 N 421

The position is excluded. - Decree of the Government of the Russian Federation of 08.07.2006 N 421

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Psychotropic substances

Amobarbital (Barbamil)

Amfepramone (fepranone, diethylpropion) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation of October 30, 2010 N 882)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Phenmetrazine

Phentermine

Ethaminal sodium (Pentobarbital)

(As amended by Decree of the Government of the Russian Federation of 30.06.2010 N 486)

Halcion (triazolam)

Isomers (unless expressly excluded) of the narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such isomers is possible within the framework of this chemical designation

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Stereoisomers (unless expressly excluded) of the narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such stereoisomers is possible within the framework of this chemical designation

(introduced by Decree of the Government of the Russian Federation of 08.07.2006 N 421)

Salts of all narcotic drugs and psychotropic substances listed in this list, if the existence of such salts is possible

List of psychotropic substances, whose turnover

in the Russian Federation is also limited in relation to

which allow the exclusion of certain measures

control in accordance with the law

Russian Federation and international treaties

Russian Federation (list III)

(as amended by Decree of the Government of the Russian Federation of 04.07.2007 N 427)

Allobarbital

Amineptine

Aminorex

Benzphetamine

Butalbital

Butobarbital

Butorphanol

(introduced by Decree of the Government of the Russian Federation of June 30, 2010 N 486)

Vinylbital

Galazepam

Haloxazolam

Gammabutyrolactone (introduced by Decree of the Government of the Russian Federation of February 22, 2012 N 144)

Gammabutyrolactone

(introduced by Decree of the Government of the Russian Federation of February 22, 2012 N 144)

Sodium 4-hydroxybutyrate and other salts of hydroxybutyric acid

The position is excluded. - Decree of the Government of the Russian Federation of June 22, 2009 N 507

Dextromethorphan

Delorazepam

Kamazepam

Ketazolam

Clobazam

Cloxazolam

Clorazepate

Clothiazepam

Levamphetamine

Lephetamine

Loprazolam

Lormetazepam

Mazindol

Methylphenobarbital

Methylprilon

Mefenorex

Nalbuphine [(5-alpha, 6-alpha)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol] (introduced by Decree of the Government of the Russian Federation of April 23, 2012 N 359)

The position is excluded. - Decree of the Government of the Russian Federation of 08.12.2010 N 990

Nimetazepam

Nordazepam

Oxazolam

- hydroxybutyric acid

(introduced by Decree of the Government of the Russian Federation of December 8, 2010 N 990)

The position is excluded. - Decree of the Government of the Russian Federation of June 30, 2010 N 486

Pinazepam

pipradrol

Pirovaleron

prazepam

Secbutabarbital

Secobarbital

Tianeptine

(introduced by Decree of the Government of the Russian Federation of June 30, 2010 N 486)

Phendimetrazine

Phencamfamin

Fenproporex

fludiazepam

Cyclobarbital

Zipeprol

Ethyl loflazepat

ethylamphetamine

Etinamat

Ethchlorvinol

Salts of substances listed in this list, if the existence of such salts is possible

<*>Including salts of substances listed in the table, if the existence of such salts is possible, excluding salts of sulfuric, hydrochloric and acetic acids.

Notes. 1. The assignment of a substance to the corresponding narcotic drug, psychotropic substance or their precursor included in this list does not depend on what brand (trade) names, synonyms or abbreviations are used as its name. (clause 1 as amended by Decree of the Government of the Russian Federation of 03.06.2010 N 398)

2. The control applies to preparations containing narcotic drugs and psychotropic substances specified in this list, regardless of their quantity and the presence of neutral components (water, starch, sugar, sodium bicarbonate, talc, etc.). (As amended by the Resolution Government of the Russian Federation of 03.06.2010 N 398)

For combined medicinal products containing, in addition to the main controlled substance, other pharmacologically active components, control is established on an individual basis by including this combined medicinal product in the appropriate list of this list.

3. A preparation containing several precursors included in the tables of list IV of this list is controlled as the precursor contained in it, provided for in the table of list IV of this list, which has the lowest serial number. (clause 3 as amended by Decree of the Government of the Russian Federation of 03.06.2010 N 398)

5. The concentration of substances specified in list IV of this list is determined based on the mass fraction of the substance in the composition of the mixture (solution). (clause 5 was introduced by Decree of the Government of the Russian Federation of 03.06.2010 N 398)

6. Derivatives of narcotic drugs and psychotropic substances are substances of synthetic or natural origin, which are not included in independent positions in the state register of medicines or in this list, the chemical structure of which is formed by the replacement (formal substitution) of one or more hydrogen atoms, halogens and (or) hydroxyl groups in the chemical structure of the corresponding narcotic drug or psychotropic substance into other monovalent and (or) divalent atoms or substituents (with the exception of hydroxyl and carboxyl groups), the total number of carbon atoms in which should not exceed the number of carbon atoms in the original chemical structure of the corresponding narcotic drug or a psychotropic substance.

If the same substance can be classified as a derivative of several narcotic drugs or psychotropic substances, it is recognized as a derivative of a narcotic drug or psychotropic substance, the change in the chemical structure of which requires the introduction of the smallest number of substituents and atoms. (clause 6 was introduced by Decree of the Government of the Russian Federation of November 19, 2012 N 1178)

Substances and methods prohibited at all times

(out-of-competition and competitive periods)

Prohibited Substances

S1 - Androgens; Anabolic steroids and their analogues

S2 - Peptide hormones; Growth factors and their analogues

S3 - Beta-2 agonists (β2-agonists)

S4 - Hormones; Hormone antagonists; Metabolism modulators

S5 - Diuretics; Masking agents

Prohibited Methods

M1 - Manipulation of blood and its components

The following methods are prohibited:

1. Primary or repeated introduction of blood of autologous, allogeneic (homologous) or heterologous origin, or red blood cell preparations of any origin into the cardiovascular system.

2. Artificial improvement in the processes of consumption, transport or delivery of oxygen, including, but not limited to: the use of fluorine derivatives, efaproxiral (RSR13) and modified hemoglobin-based drugs (for example, hemoglobin-based blood substitutes, microencapsulated hemoglobin), with the exception of the introduction supplemental oxygen by inhalation.

3. Any form of intravascular manipulation with blood or its components by physical or chemical methods

M2 - Chemical and physical manipulation

The following methods are prohibited:

1. Falsification, as well as attempts to falsify samples taken as part of the doping control procedure in order to violate their integrity and authenticity. These manipulations include, but are not limited to: Actions to change urine and/or change its properties in order to complicate analysis (for example, the introduction of protease enzymes).

M3 - Gene doping

Prohibited as capable of improving athletic performance:

1. Transfer of nucleic acid polymers or nucleic acid analogues.

2. The use of gene editing agents aimed at changing the genomic sequence and/or transcriptional or epigenetic regulation of gene expression.

3. Use of normal or genetically modified cells.

Substances and methods prohibited in-competition

S6 - Stimulants (Adrenergic agonists; Psychostimulants, etc.)

S7 - Drugs

S8 - Cannabinoids; cannabimimetics

S9 - Glucocorticosteroids (GCS) - IM, IV, per os, per rectum

Substances prohibited in certain sports

P1 - Beta-blockers

Unless otherwise noted, beta-blockers are prohibited in-competition only in the following sports:

Motorsport (FIA)

Billiard sport (all disciplines) (WCBS)

Golf (IGF)

Darts (WDF)

Skiing/Snowboarding (FIS)

Scuba diving (CMAS)

Shooting (ISSF, IPC) (also prohibited out of competition)

Archery (WA) (also prohibited out of competition).

World
anti-doping
agency

World Anti-Doping Code

INTERNATIONAL STANDARD

WORLD ANTI-DOPING CODE
PROHIBITED LIST 2009

The use of any drug should be limited to medical indications.

All Prohibited Substances are considered "Specified Substances" with the exception of substances listed in Classes S1, S2, S4.4, S6.a and in the Prohibited Methods section of Classes M1, M2 and M3.

SUBSTANCES AND METHODS PROHIBITED AT ALL TIME
(BOTH IN-COMPETITIVE AND OUT-COMPETITIVE)

PROHIBITED SUBSTANCES

S1. ANABOLIC AGENTS

The use of anabolic agents is prohibited.

1. Anabolic androgenic steroids (AAS)

a) Exogenous* AAS, including

1-androstenediol (5α-androsta-1-en-3β,17β-diol)
1-androstenedione (5α-androsta-1-ene-3,17-dione)
bolandiol (19-norandrostenediol)
bolasterone
boldenone
boldion (androsta-1,4-diene-3,17-dione)
gestrinone 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)
danazol (17α-ethynyl-17β-hydroxyandrosta-4-enoisoxazole)
dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrost-1,4-dien-3-one)
deoxymethyltestosterone (17α-methyl-5α-androsta-2-en-17β-ol)
drostanolone
gestrinone 4hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one);
calusterone
quinbolone
clostebol
mestanolone
Mesterolone
methandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
methandriol
methasterone (2α,17α-dimethyl-5α-androstan-3-on-17β-ol)
methenolone
methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one)
methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien-3-one)
methylnortestosterone (17β-hydroxy-17α-methylestra-4-en-3-one)
methyltestosterone
methyltrienolone (17β-hydroxy-17α-methylestra-4,9,11-trien-3-one)
mibolerone
19-norandrostenedione (estra-4-en-3,17-dione)
nandrolone
norboleton
norclostebol
norethandrolone
oxabolone
oxandrolone
oxymesterone
oxymetholone
prostanozole (17β-hydroxy-5α-androstanopyrazole)
stanozolol
stenbolone
1-testosterone (17β-hydroxy-5α-androst-1-en-3-one)
tetrahydrogestrinone (18α-homo-pregna-4,9,11-trien-17β-ol-3-one)
trenbolone
fluoxymesterone
formebolone
furazabol (17β-hydroxy-17α-methyl-5α-androsta--furazan)
quinbolone
ethylestrenol (19-nor-17α-pregna-4-en-17-ol)

b) Endogenous** AAS when administered exogenously:

androstenediol (androsta-5-en-3β,17β-diol)
androstenedione (androsta-4-ene-3,17-dione)
dihydrotestosterone (17β-hydroxy-5α-androst-3-one)
prasterone (dihydroepiandrosterone, DHEA)
testosterone,

as well as the following metabolites and isomers:

4-androstenediol (androsta-4-en-3β,17β-diol)
5α-androstane-3α,17α-diol
5α-androstane-3α,17β-diol
5α-androstan-3β,17α-diol
5α-androstane-3β,17β-diol
5-androstenedione (androsta-5-en-3,17-dione)
androsta-4-en-3α,17α-diol
androsta-4-en-3α,17β-diol
androsta-4-en-3β,17α-diol
androsta-5-en-3α,17α-diol
androsta-5-en-3α,17β-diol
androsta-5-en-3β,17α-diol
3α-hydroxy-5α-androstan-17-one
3β-hydroxy-5α-androstan-17-one
19-norandrosterone
19-norethiocholanolone
epi-testosterone
epi-dihydrotestosterone

Comments on class S1.1b:

If any of the anabolic androgenic steroids can be produced endogenously (naturally), then the Sample will be considered to contain a prohibited substance and the Analytical Finding will be Adverse if the concentration of the prohibited substance or its metabolites or markers and/or their respective ratios in the Athlete's Sample are outside the limits normal values ​​found in humans and corresponding to normal endogenous production by the body. Under no circumstances will a Sample be considered to contain a Prohibited Substance if the Athlete establishes that the concentrations of the Prohibited Substance or its metabolites or markers and/or their respective ratios in the Athlete's Sample may be due to a pathological or physiological condition.

In all cases and at all concentrations, the Athlete's Sample will be considered to contain a Prohibited Substance and the laboratory will report an Adverse Analytical Finding if, based on any reliable analytical method (for example, IRMS – Isotope Ratio Mass Spectrometry), it can demonstrate that the Prohibited Substance is origin. In such cases, no further investigation is carried out.

If concentrations or ratios do not exceed normal human values ​​and reliable analytical methods (such as IRMS) do not reveal an exogenous origin of the substances, but there are strong data, such as comparison of endogenous steroid profiles, indicating the possible use of a prohibited substance, or the laboratory reports a ratio testosterone to epitestosterone (T/E) concentrations greater than four (4) to one (1), and reliable methods of analysis (e.g. IRMS) have not shown an exogenous origin of the substance, then further studies should be conducted by the Anti-Doping Organization by comparison with the results of previous testing or conducting subsequent tests.

When further investigations are needed, the test result obtained from the laboratory is declared atypical rather than adverse. If the laboratory reports that additional reliable methods of analysis (eg IRMS) have identified the exogenous origin of the Prohibited Substance, then no further investigation is required and the Sample will be considered to contain that Prohibited Substance. When additional reliable analytical methods (e.g. IRMS) have not been applied and the results of at least three previous tests are not known, then further long-term studies of the athlete profile through at least three unannounced (unannounced) tests within three consecutive months must be conducted by the appropriate Anti-Doping Organization . The result that triggered this long-term study is declared atypical. If the athlete's profile, as determined by long-term studies, is not physiologically normal, then the result will be declared unfavorable.

In extremely rare individual cases, the urine may contain endogenous boldenone in very low concentrations (several nanograms per milliliter (ng / ml)). If the laboratory reports such a case, and the use of any reliable analytical methods (for example, IRMS) does not reveal the exogenous origin of the substance, then further investigation can be carried out by conducting additional tests.

If a laboratory reports the detection of 19-norandrosterone, the test result will be considered an adverse test result, as the detection of this substance is scientifically substantiated confirmation of the exogenous origin of the prohibited substance. In such cases, no further investigation is carried out.

If the Athlete refuses to cooperate during the course of the study, the Athlete's Sample will be considered to contain a Prohibited Substance.

2. Other anabolic agents (the list is not exhaustive):

clenbuterol
selective androgen receptor modulators (SARMs)
tibolone
zeranol
zilpaterol

In this section:
*"exogenous" substances means substances that cannot be produced by the body.
**"endogenous" substances means substances that can be produced naturally by the body.

S2. HORMONES AND RELATED SUBSTANCES

The following substances and their releasing factors are prohibited:

1. Agents that stimulate the production of erythropoietin (erythropoiesis): Erythropoietin (EPO, EPO), darbepoetin (dEPO), hematide;
2. Growth hormone (hGH), insulin-like growth factors (eg, IGF-1), mechanical growth factors (MGFs);
3. Chorionic gonadotropin (hCG) and luteinizing hormone (LH) are prohibited only for men;
4. Insulins;
5. Corticotropins;

and other substances with a similar chemical structure or similar biological effects.

Comments on class S2:

Unless the Athlete establishes that the elevated concentration of a Substance is due to a physiological or pathological condition, the Sample will be considered to contain any of the Prohibited Substances listed above if the concentrations of the Prohibited Substances or their metabolites or markers and/or their respective ratios in the Athlete's Samples are outside the limits normal values ​​that are found in humans and correspond to normal endogenous production by the body.

If the laboratory reports, based on a reliable analytical method, that the Prohibited Substance is of exogenous origin, then the Sample will be considered to contain a Prohibited Substance and will be declared an Adverse Analytical Finding.

S3. BETA-2 AGONISTS

All beta-2 agonists are prohibited, including their D- and L-isomers.

Thus, formoterol, salbutamol, salmeterol and terbutaline, when administered by inhalation, require a Therapeutic Use Exemption in accordance with the International Standard for Therapeutic Use Exemptions.

Regardless of whether or not a Therapeutic Use Exemption has been obtained, the presence of salbutamol in excess of 1000 ng/mL will be considered an Adverse Analytical Finding unless the Athlete can demonstrate, through a controlled pharmacokinetic study, that the finding is due to the use of therapeutic doses of salbutamol by inhalation.

S4. HORMONAL ANTAGONISTS AND MODULATORS

The following classes are prohibited:

1. Aromatase inhibitors, including but not limited to: anastrozole, letrozole, aminoglutethimide, exemestane, formestane, testolactone.

2. Selective estrogen receptor modulators (SERMs), including but not limited to these substances: raloxifene, tamoxifen, toremifene.

3. Other antiestrogenic substances, including but not limited to: clomiphene, cyclophenyl, fulvestrant.

4. Myostatin function altering agents, including but not limited to myostatin inhibitors.

S5. DIURETICS AND OTHER MASKING AGENTS

Masking agents are prohibited. These include:

Diuretics, probenecid, plasma expanders (eg, intravenous albumin, dextran, hydroxyethyl starch, and mannitol)
and other substances with similar biological effects.

Diuretics include:

amiloride
acetazolamide
bumetanide
indapamide
canrenone
metolazone
spironolactone
thiazides (eg bendroflumethiazide, chlorothiazide, hydrochlorothiazide) triamterene
furosemide
chlorthalidone
ethacrynic acid,

and other substances with a similar chemical structure or similar biological effects, with the exception of drosperinone and topical dorzolamine, which are not prohibited.

Comments on class S5:
A Therapeutic Use Exemption is invalid if the Athlete's urine contains a Prohibited Substance at a threshold or subthreshold concentration in addition to a diuretic.

PROHIBITED METHODS

M1. INCREASED OXYGEN TRANSFER

The following methods are prohibited:

1. Blood doping, including the use of blood of autologous, homologous or heterologous origin, or red blood cells of any origin.

2. Artificial increase in oxygen consumption, transport or delivery due to the use of perfluorates, efaproxiral (RSR13) or modified hemoglobin products (such as hemoglobin-based blood substitutes or microencapsulated hemoproducts), while not limited to this listing.

M2. CHEMICAL AND PHYSICAL MANIPULATIONS
1. Tampering with, or attempting to falsify, Doping Control Samples in order to compromise their integrity or authenticity is prohibited. These manipulations include catheterization, urine substitution or changes in its properties, and are not limited to this listing.

2. Intravenous infusions (infusions) are prohibited except in cases of surgery, emergency medical care and clinical research.

MZ. GENE DOPING

The transfer of cells or genetically significant elements or the use of cells, genetically significant elements or pharmacological agents that modulate (alter) the expression of genes that can improve athletic performance is prohibited.

Peroxisome proliferating activated delta receptor (PPARdelta) agonists, eg GW 1516 type, and PPARdelta-AMP-activated protein kinase (AMPK) axis agonists, eg FICAR type, are prohibited.

SUBSTANCES AND METHODS,
PROHIBITED DURING COMPETITIONS

In addition to the substance classes listed in S1-S5 and M1-M3, the following classes are prohibited during competition:
PROHIBITED SUBSTANCES

S6. STIMULANTS

All stimulants, including both their optical isomers (D- and L-), if any, are prohibited. The exception is imidazole applied topically, as well as stimulants included in the Monitoring Program for 2009*.

Stimulants include:

a) stimulants that do not have a special specific application:

adrafinil
amifenazole
amfepramone
amphetamine
amphetamine
benzphetamine
benzylpiperazine
bromantane
dimethylamphetamine
clobenzorex
cocaine
cropropamide
crotetamide
mesocarb
methamphetamine (D-)
methylenedioxyamphetamine
methylenedioxymethamphetamine
p-methylamphetamine
mefenorex
mefentermine
modafinil
norfenfluramine
prolintan
famprofazon
phendimetrazine
4-Phenylperacetam (Carphedon, Phenotropil)
fenetylline
phencamine
phenmetrazine
fenproporex
phentermine
fenfluramine
furfenorex
ethylamphetamine

Stimulants not included in this list are considered to be stimulants that have specific uses.

Translator's note: to explain which stimulants may have their own, special, specifics of use, the 2008 Prohibited List had an explanation that was not included in the current version of the list: “The prohibited list may contain special (specific) substances, the use of which can be considered as unintentional due to their public availability or the dubiousness of their ability to influence sports results.

b) Stimulants with specific application:

adrenalin**
heptaminol
isometheptene
cathin***
levmethamphetamine
meclofenoxate
methylphenidate
methylephedrine****
nikethamide
norfenephrine
oxilofrine
octopamine
parahydroxyamphetamine
pemoline
pentetrazole
propylhexedrine
selegiline
sibutramine
strychnine
tuaminoheptane
fenbutrazate
fencamfamine
phenpromethamine
etamivan
ethylenefrin
ephedrine****

* The Monitoring Program for 2009 includes the following non-banned substances: bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradol, pseudoephedrine, synephrine.

** Andrenaline contained in preparations for local anesthesia or for topical use (for example, nasal or ophthalmic) is not considered a Prohibited Substance.

*** Cathin is prohibited (the sample is considered positive) if its content
in urine exceeds 5 micrograms per milliliter.

**** Ephedrine and methylephedrine are prohibited (the sample is considered positive),
if the content of each of them in the urine exceeds 10 micrograms per milliliter.

S7. DRUGS

The following drugs are prohibited:

buprenorphine
hydromorphine
dextromoramide
diamorphine (heroin)
methadone
morphine
oxycodone
oxymorphone
pentazocine
pethidine.
fentanyl and its derivatives.

S8. CANNABINOIDS

Cannabinoids, such as marijuana, hashish, are prohibited.

S9. GLUCOCORTICOSTEROIDS

The use of glucocorticosteroids is prohibited orally, rectally, intravenously or intramuscularly.

In accordance with the International Standard for Therapeutic Use Exemptions, a declaration for the use of glucocorticosteroids is made by the Athlete for intra-articular, peri-articular, intra-ligamentous, epidural and intradermal use and inhalation, with the exception of the following methods.

Topical preparations applied to the skin (including iontophoresis and phonophoresis), gums, perianal area, as well as drops in the ears, nose and eyes are not prohibited, and their use does not require a declaration of use.

SUBSTANCES PROHIBITED IN CERTAIN SPORTS
P1. ALCOHOL

Alcohol (ethanol) is only prohibited in competition in the sports listed below. It is determined by analyzing exhaled air and/or blood. A violation of the rules and a case of doping is considered to be an excess of the threshold concentration (content in the blood) equal to 0.10 g per liter.

Aeronautics (FAI)
Archery (FITA, IPC)
Motorsport (FIA)
Bowling (IPC bowls)

Karate (WKF)
Modern Pentathlon (UIPM)
for disciplines involving shooting
Motorsport (FIM)
Powerboat sport (UIM)

R2. BETA BLOCKERS

Unless otherwise stated, beta-blockers are only prohibited in competition in the following sports:

Aeronautics (FAI)
Motorsport (FIA)
Billiard Sports (WCBS)
Bobsleigh (FIBT)
Wrestling (FILA)
Bowling (CMSB, IPC bowls)
Bowling nine and ten pin (FIQ)
Bridge (FMB)
Powerboat sport (UIM)
Gymnastics (FIG)
Curling (WCF)
Skiing/Snowboarding (FIS) (ski jumping, freestyle, snowboarding)
Motorsport (FIM)
Sailing (ISAF) (match racing only)
Modern Pentathlon (UIPM) for disciplines that include shooting
Archery (FITA, IPC) (permanently banned)
Shooting (ISSF, IPC) (permanently prohibited)

Beta blockers include (the list is not exhaustive):

alprenolol
atenolol
acebutolol
betaxolol
bisoprolol
bunolol
carvediol
carteolol
labetalol
levobunolol
metipranolol
metoprolol
overwhelmed
oxprenolol
pindolol
propanolol
sotalol
timolol
celiprolol
esmolol

Prohibited List 2009

Summary of major changes and clarifications

Introduction
- Article 4.2.2 of the 2009 World Anti-Doping Code states: “All Prohibited Substances, with the exception of substances of the class of anabolic agents and hormones, as well as stimulant substances, specified in the Prohibited List, will be considered “specified” substances for the purposes of Article 10 (Sanctions athletes in individual sports). Prohibited methods will not be treated as special substances.”
These changes are reflected in the Prohibited List by introducing the following phrase: "All Prohibited Substances are considered as 'Specified Substances' with the exception of substances listed in classes S1, S2, S4.4, S6.a and in the section of Prohibited Methods in classes M1, M2 and M3.

SUBSTANCES AND METHODS PROHIBITED AT ALL TIME (BOTH IN-COMPETITIVE AND OUT OF-COMPETITIVE)

S1. Anabolic agents
1- Anabolic androgenic steroids
- The prostanazole nomenclature has been changed to 17β-hydroxy-5α-androsta pyrazole to better meet the requirements of the International Union of Fine and Applied Chemistry (IUPAC).
- Epitestosterone has been moved from section S5 (diuretics and other masking agents) to section S1 (anabolic agents and endogenous anabolic androgenic agents), as this substance belongs to the testosterone isomer. Thus, epitestosterone will retain its status as a non-specific substance when deciding whether to impose sanctions.
- In accordance with the format of the World Anti-Doping Code, the classification of atypical endogenous AAS results has been moved to the commentary category.

S2. Hormones and similar substances
- To reflect the heterogeneity of new types of EPO-like substances in development, the term "erythropoietin" is replaced by the phrase "agents that stimulate erythropoiesis".
- HCG and LH are clearly labeled as gonadotropins, which are prohibited in men.
- The explanation at the end of this section has been converted into a commentary, taking into account the format of the World Anti-Doping Code.

S3. Beta-2 agonists

- According to the new edition of the International Standard for Therapeutic Use Exemptions, use of inhaled forms of formatrol, salbutamol, salmeterol and terbutaline requires a Therapeutic Use Exemption.
- If salbutamol concentrations exceeding 1000 ng/L are detected in the urine sample, this fact will be classified as a negative test result until such time as the athlete can prove using a controlled pharmacokinetic study that the abnormal result is a consequence of the use of a therapeutic dose of inhalation form of salbtamol. A controlled pharmacokinetic study should be performed in a hospital setting or a specialized medical center for the control of this medical condition, where the prescribed dose can be clearly monitored and the analysis procedure is clearly documented.

S5. Diuretics and other masking agents
- As stated above, epitestosterone has been moved to section S1.
- Alpha reductase inhibitors are no longer classified as prohibited substances. A detailed study of steroid profiles has proved the ineffectiveness of their use as masking agents.

The phrase “intravenous administration” now precedes examples indicating agents that increase plasma volume - albumin, dextran, hydroxyethyl starch, to emphasize the fact that these substances are prohibited only when administered by this route; mannitol added as an example; use of the inhaled form of mannitol is allowed, for example, when conducting a provocative test for asthma.

It was stated that the inhibitors of carbonic anhydrase - dorzalomide and brinzolamide when locally injected into the eyeball - are not prohibited. The logical explanation for this exception is that these drugs do not show a diuretic effect when applied topically.

Prohibited Methods

M2. Chemical and physical manipulations
- Intravenous infusions are prohibited and therefore require a Therapeutic Use Exemption except for surgery, emergency medical care or clinical examination. The purpose of this section is to prohibit the use of hemodilution, overhydration, and the administration of prohibited substances by intravenous infusion. Intravenous infusion is defined as the process of delivering fluids through a vein using a needle or similar device. The following are non-prohibited, medically justified and medically permitted cases of performing intravenous infusions:

1. Emergency cases, including resuscitation;
2. Blood transfusion resulting from blood loss;
3. Carrying out surgical interventions;
4. The introduction of drugs and fluids, when other routes of administration are not possible (for example, incessant vomiting) according to generally accepted medical practice, carrying out induced dehydration in special cases.
Performing injections using a conventional syringe is not prohibited if the injected substance is not prohibited, and the volume of the administered drug does not exceed 50 ml.

M3. Gene doping
- The definition of "gene doping" has been changed to better reflect the technological possibilities in this area.
- Taking into account the latest scientific data, agonists of the peroxime proliferating activated delta receptor and axis agonists of AMP activated protein kinase have been added to the list.

Substances and methods prohibited during the competition

S6. Stimulants
- Subject to Article 4.2.2 of the new edition of the Code, the Ranking Committee has identified all stimulants listed on the 2008 Prohibited List as either specific or non-specific. The facts were taken into account that there is a possibility of applying for permission for therapeutic use and their pharmacological properties, which can improve sports performance, harm health, their widespread use in the form of components of commercially available drugs, legal availability on the market, illegal use, legal/controlled status, precedent and potential abuse in sports practice, transition to amphetamine and/or methamphetamine phase. All non-specific stimulants are listed in section S6.a, while a list of examples of specific stimulants is included in section S6.b.
- Prior to the decision and re-listing of pseudoephedrine, it was determined that additional information and research was required to investigate the effect of this substance. Thus, pseudoephedrine remains in the monitoring program.

S9. Glucocorticosteroids
- In accordance with the provisions of the 2009 Code, references to the abbreviated TI have been removed.
- In accordance with the International Standard for Therapeutic Use Exemptions, an athlete must complete a declaration on the use of glucocorticosteroids for intraarticular, periarticular, intraligamentous, epidural, intradermal and inhalation routes of administration.
- A TUE or declaration is not required for topical use of glucocorticosteroids.

Substances prohibited in certain sports

P1. Alcohol
- For all International Federations, the doping threshold in blood and in exhaled air has been harmonized, which is 0.1 g / liter.
- At the request of the International Bowling Federation (FIQ), nine-pin bowling is included. The WADA sequencing committee also included ten pin bowling as it is represented by the FIQ.

P2. Beta blockers
- At the request of the International Bowling Federation (FIQ), the name of the nine-pin bowling has been corrected. The WADA Ranking Committee also included 10-pin bowling in this category, as this discipline is represented by the FIQ.
- At the request of the International Golf Federation, beta-blockers are prohibited in the discipline of golf.

Special Substances

This section has been excluded, since the definition of “special substances” has changed in the new version of the Code. A distinction has been made between "specified substances" and "prohibited substances", which are now included in the aquatic part.

Monitoring program for 2009 *
The substances listed below were included in the monitoring program for 2009:
1. Stimulants, in-competition only: bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradol, pseudoephedrine, synephrine.
2. Drugs, in-competition only: morphine/codeine combination.

*The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with signatories and governments, shall establish a monitoring program for substances that are not on the Prohibited List but whose abuse WADA wishes to monitor for misuse in sport.”

Decree of the Government of the Russian Federation of June 30, 1998 N 681
"On approval of the list of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation"

With changes and additions from:

February 6, November 17, 2004, July 8, 2006, July 4, 2007, June 22, December 21, 31, 2009, April 21, June 3, 30, July 29, October 30, November 27, 8 December 2010, February 25, March 11, July 7, October 6, December 8, 2011, February 22, March 3, April 23, May 18, September 4, October 1, November 19, 23, 2012, 4 , February 26, June 13, July 10, September 9, November 7, December 16, 2013, March 22, May 31, June 23, October 25, December 9, 2014, February 27, April 9, May 8, 2 July, October 12, 2015, April 1, 2016, January 18, February 21, May 25, July 12, 29, 2017, June 22, 2018

ON APPROVAL OF THE LIST OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS SUBJECT TO CONTROL IN THE RUSSIAN FEDERATION

In accordance with the Federal Law "On Narcotic Drugs and Psychotropic Substances" (Sobraniye Zakonodatelstva Rossiyskoy Federatsii, 1998, No. 2, Art. 219), the Government of the Russian Federation decides:

Approve the attached list of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation.

Establish that amendments and additions to the specified list are carried out on the proposal of the Ministry of Health of the Russian Federation jointly with the Ministry of Internal Affairs of the Russian Federation.

Chairman of the Government of the Russian Federation S. KIRIENKO
Approved by Decree of the Government of the Russian Federation of June 30, 1998 N 681

LIST OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS SUBJECT TO CONTROL IN THE RUSSIAN FEDERATION

List of narcotic drugs and psychotropic substances whose circulation in the Russian Federation is prohibited in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List I)

• Allylprodine
• Alfameprodine
• Alfamethadol
• Alpha - methylfentanyl
• Alpha - methylthiofentanyl
• Alphaprodin
• Alphaacetylmethadol
• anileridin
• Acetyl - alphamethylfentanyl
• Acetylhydrocodeine
• Acetylated opium
• Acetylcodeine
• Acetylmethadol
• Acetorphin
• BDB (L-(3,4-methylenedioxyphenyl)-2-butanamine)
• Bezitramid
• Benzetidine
• benzylmorphine
• Beta-hydroxy-3-methylfentanyl
• Beta-hydroxyfentanyl
• Betameprodine
• Betamethadol
• Betaprodin
• Betacetylmethadol
• Hashish (pineapple, cannabis resin)
• Heroin (diacetylmorphine)
• hydrocodone
• Hydrocodone phosphate
• N-hydroxy-MDA
• Hydromorphinol
• Hydromorphone
• Desomorphine
• Diampromide
• Diacetylmorphine (heroin)
• Dihydromorphine
• Dimenoxadol
• N-dimethylamphetamine
• Dimepheptanol
• Dimethylthiambutene
• Dioxafetyl butyrate
• Dipipanon
• Diphenoxin
• Diethylthiambutene
• DMA (d,L-2,5-dimethoxy-alpha-methyl-phenyl-ethylamine)
• DMHP (dimethylheptylpyran)
• DMT (dimethyltryptamine)
• DOB (d,L-2,5-dimethoxy-4-bromo-amphetamine)
• DOC (d, L-2,5-dimethoxy-4-chloro-amphetamine)
• DOET (d, L-2,5-dimethoxy-4-ethyl-amphetamine)
• Drotebanol
• DET (N,N-diethyltryptamine)
• Isomethadone
• Cannabis (marijuana)
• Ketobemidone
• Clonitazen
• Kodoxim
• coca bush
• Homemade preparations made from ephedrine or preparations containing ephedrine
• Homemade preparations of pseudoephedrine or preparations containing pseudoephedrine
• Levomethorphan
• Levomoramid
• Levorphanol (lemoran)
• Levofenacylmorphan
• Lysergic acid and its derivatives
• d-Lysergide (LSD, LSD-25)
• coca leaf
• poppy straw
• Cannabis oil (hash oil)
• MBDB (N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine)
• MDA (tenamphetamine)
• MDMA (d, L-3,4-methylenedioxy-N-alpha-dimethyl-phenyl-ethylamine)
• 3-Monoacetylmorphine
• 6-Monoacetylmorphine
• Mescaline
• Methadone
• d-methadone
• L-methadone
• Methadone intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane)
• Metazocin
• methamphetamine
• Methyldesorphin
• Methyldihydromorphine
• 3-methylthiofentanyl
• 3-methylfentanyl
• N-methylephedron
• metopon
• Mirofin
• Milky juice of various types of poppy that are not opium or oil poppy, but contain poppy alkaloids included in the lists of narcotic drugs and psychotropic substances
• MMDA (2-methoxy-alpha-4-methyl 4,5-(methylenedioxy)-phenethylamine)
• Moramide, intermediate (2-methyl-3-morpholine-1, 1-diphenyl-propane-carboxylic acid)
• Morferidine
• Morphine methyl bromide
• Morphine-N-oxide
• MPPP (1-methyl-4-phenyl-4-piperidinol propionate (ether))
• nicodicodin
• Hikokodin
• Hicomorphine
• Horacimetadol
• Norcodeine
• Norlevorphanol
• Normethadone
• Normorphine
• Norpipanon
• Oxycodone (tecodin)
• Oxymorphone
• Opium (including medical) - curdled juice of the opium or oil poppy
• Opium poppy (Papaver somniferum L)
• oripavin
• Para - fluorofentanil (para - fluorofentanyl)
• parahexyl
• PEPAP (L-phenethyl-4-phenyl-4-piperidinol acetate (ether))
• Pethidine
• Pethidine intermediate A (4-cyano-1-methyl-4-phenylpiperidine)
• Piminodin
• Fruiting body (any part) of any type of mushroom containing psilocybin and/or psilocin
• PMA (4-methoxy-alpha-methylphenyl-ethylamine)
• Proheptazin
• Properidine
• Propiram
• psilocybin
• psilocin
• Racemethorphan
• Racemoramide
• Racemorphan
• Rolicyclidine
• 2С-В (4-bromo-2,5-dimethoxyphenethylamine)
• STP (DOM) (2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane)
• Tebacon
• Tenocyclidine
• Tetrahydrocannabinol (all isomers)
• Thiofentanil
• TMA (d,L-3,4,5-trimethoxy-alpha-methylphenyl-amine)
• Fenadoxone
• Phenadon
• Phenazocin
• Fenampromide
• Phenatin
• phencyclidine
• Phenomorphan
• Phenoperidine
• Folcodin
• Furetidine
• Ecgonine, its esters and derivatives, which can be converted to ecgonine and cocaine
• Poppy straw extract (poppy straw concentrate)
• N-ETHYL-MDA (d, L-N-ethyl-alpha-methyl-3,4-(methylenedioxy) - phenethylamyl)
• Ethylmethylthiambutene
• Ethycyclidine
• Ethoxeridine
• Etonitazen
• Etorfin
• Etryptamine
• Ephedron (methcathinone)

• Dexamphetamine
• Cathin (d-norpseudoephedrine)
• Cathinone (L-alpha-aminopropiophenone)
• Levamphetamine
• Mecloqualone
• Methaqualone
• 4-methylaminorex
• Methylphenidate (Ritalin)
• Isomers (unless expressly excluded) of narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such isomers is possible within the framework of this chemical designation
• Esters of complex and simple narcotic drugs and psychotropic substances listed in this list
• All mixtures containing narcotic drugs and psychotropic substances of this list, regardless of their quantity

List of narcotic drugs and psychotropic substances, the circulation of which in the Russian Federation is limited and in respect of which control measures are established in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List II)

• p-Aminopropiophenone (PAPP) and its optical isomers (cyanide antidote)
• Alfentanil
• Amphetamine (phenamine) and combination medicines containing phenamine (amphetamine)
• Buprenorphine
• Glutethimide (Hoxyron)
• Dextromoramide
• Dextropropoxyphene (ibuproxiron, proxivon, spasmoproxyvon)
• Dihydrocodeine
• diphenoxylate
• Codeine
• Codeine Phosphate
• Cocaine
• cocaine hydrochloride
• Codeine N-oxide
• Morphine
• Morphine hydrochloride
• Morphine sulfate
• Morphylong
• Omnopon
• Pentazocine
• Properidine
• Propiram
• Prosidol
• Pyritramide (dipidolor)
• Reazek
• Candles tilidina in different dosages
• Sombrevin
• Sufentanil
• Tablets "Alnagon" (codeine phosphate 20 mg, caffeine 80 mg, phenobarbital 20 mg, acetylsalicylic acid 20 mg)
• Tablets (codeine camphosulfonate 0.025 g, potassium sulfagviacol 0.100 g, grindelia thick extract 0.017 g)
• Codeine tablets 0.03 g + paracetamol 0.500 g
• Codeine phosphate tablets 0.015 g + sugar 0.25 g
• Codeine tablets 0.01 g, 0.015 g + sugar 0.25 g
• Codeine tablets 0.015 g + sodium bicarbonate 0.25 g
• Tablets "Kodterpin" (codeine 0.015 g + sodium bicarbonate 0.25 g + terpinhydrate 0.25 g)
• Cough tablets. Ingredients: powdered thermopsis herbs - 0.01 g (0.02 g), codeine - 0.02 g (0.01 g), sodium bicarbonate - 0.2 g, licorice root powder - 0.2 g
• Thebaine
• Tilidin
• Trimeperidine (promedol)
• Fentanyl
• ethylmorphine
• Escodol
• Estocin
• Estocin hydrochloride
• Ethylmorphine hydrochloride

• Amobarbital (Barbamil)
• Amfepramone (fepranone, diethylpropion)
• Ketamine
• Ketamine hydrochloride (calypsol, ketalar)
• Tablets (Barbamil 0.15 g + Bromisova 0.15 g)
• Phenmetrazine
• Phentermine
• Ethaminal sodium
• Halcion (triazolam)
• Salts of all narcotic drugs and psychotropic substances listed in this list, if the existence of such salts is possible

List of psychotropic substances whose circulation in the Russian Federation is restricted and for which the exclusion of certain control measures is allowed in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List III)

• Aminorex
• Aprofen
• Benzphetamine
• Halothane (fluorothane)
• Dextromethorphan
• Levamphetamine
• Lephetamine
• Mazindol
• Mefenorex
• Sodium hydroxybutyrate and other salts of hydroxybutyric acid
• Pentobarbital
• pipradrol
• Taren
• Phendimetrazine
• Fenproporex
• Zipeprol
• ethylamphetamine
• Salts of substances listed in this list, if the existence of such salts is possible

List of precursors whose turnover in the Russian Federation is limited and for which control measures are established in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List IV)

• Acetic anhydride
• Anthranilic acid
• N-acetylanthranilic acid
• Acetone
• Isosafrole
• red phosphorus
• Lysergic acid (*)
• N-Methylephedrine (*)
• 3,4-Methylenedioxyphenyl-2-propanone
• Methyl ethyl ketone (2-butanone)
• Norpseudoephedrine (*)
• Potassium permanganate
• Piperopal
• Piperidine
• Pseudoephedrine (*)
• Safrole
• Sulfuric acid, excluding its salts
• Hydrochloric acid, excluding its salts
• Toluene
• Phenylacetic acid
• Phenylpropanolamine (*)
• 1-Phenyl-2-propanone
• Ergometrine (ergonovine) (*)
• Ergotamine (*)
• Ethyl ether
• Ephedrine (*)

Notes

1. The control applies to all means and substances specified in this list, no matter what brand names (synonyms) they may be designated.
2. The control also applies to preparations containing the agents and substances specified in this list, regardless of their quantity and the presence of neutral components (water, starch, sugar, sodium bicarbonate, talc, etc.). For combined medicinal products containing, in addition to the main controlled substance, other pharmacologically active components, control is established on an individual basis by including this combined medicinal product in the appropriate list of this list.
3. Transit through the territory of the Russian Federation of narcotic drugs, psychotropic substances and their precursors included in this list is prohibited.